SILDOVIB D8 SILODOSIN 8mg. IP + DUTASTERIDE 0.5mg. IP

Sildovib D8 capsules contain silodosin 8 mg and dutasteride 0.5 mg for the signs and symptoms of benign prostatic hyperplasia in men. Main uses: treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate; improvement of urinary symptoms associated with BPH; improvement of urine flow in BPH; reduction of the risk of acute urinary retention in BPH; reduction of the risk of the need for BPH-related surgery.

Common side effects of Sildovib D8 Capsule include retrograde ejaculation; dizziness; diarrhoea; orthostatic hypotension (fall in blood pressure on standing); headache; nasal congestion or nasopharyngitis. Get medical help at once if you notice marked fall in blood pressure with fainting, especially when starting treatment; serious skin reactions or swelling of the face, lips or tongue (angioedema); harm to a male foetus if a pregnant woman handles the capsule.

Each Sildovib D8 capsule contains Silodosin 8 mg + Dutasteride 0.5 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Sildovib D8 Capsule only as your doctor advises.

The MRP of Sildovib D8 Capsule is ₹365 for a pack of 10x1x10 (Alu Alu). For chemists and distributors, the PTR is ₹278.1 and the PTS is ₹250.29.

Each Sildovib D8 capsule contains Silodosin 8 mg + Dutasteride 0.5 mg. It comes in a pack of 10x1x10 (Alu Alu).

Silodosin and dutasteride act on different targets in this capsule. Silodosin blocks alpha-1 receptors in the prostate, bladder base, bladder neck and prostatic urethra, relaxing the smooth muscle in these areas so that urine flow improves and BPH symptoms reduce. Dutasteride blocks both forms of the enzyme 5 alpha-reductase that convert testosterone into DHT, the androgen mainly responsible for development and enlargement of the prostate gland, and so the level of DHT in the body falls.

Must not be used by patients with severe renal impairment (creatinine clearance below 30 mL/min). Must not be used by patients with severe liver impairment. Must not be used together with strong CYP3A4 inhibitors such as ketoconazole, itraconazole, clarithromycin or ritonavir. Must not be used by anyone with a known allergy to silodosin, dutasteride or similar 5 alpha-reductase inhibitors; must not be used by women who are pregnant, and such women should not even handle the capsules. Must not be used together with other alpha-blockers.

Sildovib D8 Capsule is a brand of Vibcare Pharma, sold through its Genvimax division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.